These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2107600)

  • 1. Acute myocardial infarction and thrombolytic therapy.
    Yasuda T; Gold HK
    Thromb Res Suppl; 1990; 10():73-9. PubMed ID: 2107600
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac tamponade mimicking ventricular rupture after thrombolysis for acute myocardial infarction.
    Imperadore F; Spagnolli W; Martinelli L; Musuraca G; De Girolamo P; Maines M; Vergara G
    Minerva Cardioangiol; 2003 Aug; 51(4):417-8. PubMed ID: 12900724
    [No Abstract]   [Full Text] [Related]  

  • 4. [Future developments in thrombolytic therapy].
    Bode C; Runge MS
    Z Kardiol; 1993; 82 Suppl 2():187-90. PubMed ID: 8328201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part I.
    Becker RC; Corrao JM; Harrington R; Ball SP; Gore JM
    Am Heart J; 1991 Jan; 121(1 Pt 1):220-44. PubMed ID: 1898680
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneous hemarthrosis following thrombolytic therapy for acute myocardial infarction.
    Birnbaum Y; Stahl B; Rechavia E
    Int J Cardiol; 1993 Jul; 40(3):289-90. PubMed ID: 8225665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolytic therapy for acute myocardial infarct].
    Nordt TK; Bode C
    Internist (Berl); 2001 May; 42(5):659-64. PubMed ID: 11400573
    [No Abstract]   [Full Text] [Related]  

  • 8. Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction.
    Massel D; Gill JB; Cairns JA
    Can J Cardiol; 1991 Sep; 7(7):298-302. PubMed ID: 1933636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy for acute myocardial infarction: will it survive?
    Kleiman NS
    J Am Coll Cardiol; 2003 Apr; 41(8):1261-3. PubMed ID: 12706918
    [No Abstract]   [Full Text] [Related]  

  • 10. Towards improved thrombolytic therapy.
    Collen D
    Lancet; 1993 Jul; 342(8862):34-6. PubMed ID: 8100296
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolysis and percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
    Zeymer U; Neuhaus KL
    Z Kardiol; 2000; 89 Suppl 4():IV30-40. PubMed ID: 10810775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator?
    Collen D
    Ann Intern Med; 1990 Apr; 112(7):529-38. PubMed ID: 2107781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant tissue-type plasminogen activator: an infarct-sparing effect beyond thrombolysis?
    Kloner RA; Eisenhauer A
    J Am Coll Cardiol; 1992 Jul; 20(1):226-7. PubMed ID: 1607529
    [No Abstract]   [Full Text] [Related]  

  • 14. New thrombolytic regimens in acute myocardial infarction.
    Hobbach HP; Schuster P
    Lancet; 2001 Dec; 358(9298):2080. PubMed ID: 11755640
    [No Abstract]   [Full Text] [Related]  

  • 15. Evolution from fibrinolytic therapy to a fibrinolytic strategy for patients with ST-segment-elevation myocardial infarction.
    Bates ER
    Circulation; 2014 Sep; 130(14):1133-5. PubMed ID: 25161046
    [No Abstract]   [Full Text] [Related]  

  • 16. Questions and answers on treating acute myocardial infarction.
    Young JJ; Weinstock BS; Brown A
    J Invasive Cardiol; 2004 Sep; Suppl():18-21. PubMed ID: 23573666
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolytic and antiplatelet therapy in peripheral vascular disease with use of reteplase and/or abciximab. The SCVIR Consultants' Conference; May 22, 2000; Orlando, FL. Society for Cardiovascular and Interventional Radiology.
    Benenati J; Shlansky-Goldberg R; Meglin A; Seidl E;
    J Vasc Interv Radiol; 2001 Jul; 12(7):795-805. PubMed ID: 11435535
    [No Abstract]   [Full Text] [Related]  

  • 18. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Topol EJ;
    Lancet; 2001 Jun; 357(9272):1905-14. PubMed ID: 11425410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aggressive thrombolytic therapy of myocardial infarct--limits and possibilities].
    Bode C; Peter K; Kübler W; Katus HA
    Z Kardiol; 1994 Jun; 83(6):393-403. PubMed ID: 8067042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L; Lüderitz B
    Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.